CHA Comments on Stimulant Medication Shortages

CHA Comments on Stimulant Medication Shortages

Children’s health groups are asking HHS and the DEA to convene stakeholders to identify actionable solutions about ongoing stimulant medication shortages.
Download

Children's Hospital Association and other children’s health groups submitted joint comments to the Department of Health and Human Services (HHS) and the Drug Enforcement Administration (DEA) requesting the convening of stakeholders to identify actionable solutions about ongoing stimulant medication shortages.

Our comments highlight the long-term negative impacts that children and their families may experience due to untreated attention deficit hyperactivity disorder and that these shortages exacerbate existing health disparities among families enrolled in Medicaid and CHIP.

Related Content

Ensuring Access to Critical Medicines for Children

Discover how Angels for Change partners with manufacturers to prevent shortages and keep lifesaving pediatric drugs available.

Aug. 26, 2025

Reinforcing Readiness: Collaborating to End Drug Shortages

Learn why the Children’s Hospital Association partners with a nonprofit to ensure medications are always available to patients who depend on them.

Aug. 12, 2025

CHA Submits Letter on Prioritizing Pediatric Medical Research in FY26 Appropriations

In collaboration with other pediatrics-focused organizations, CHA submitted a letter highlighting FY26 appropriations requests related to federal funding for pediatric medical research.

July 31, 2025